Back to Search
MELISSA ALSINA, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1184656746IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
ME84554(FL)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
ME84554(FL)
Education
OTHER
Class of 1988
Research & Publications (20)
Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myeloma.
PMID 14726402·Blood·2004
3-trial
The impact of time on the systemic inflammatory response in pneumococcal pneumonia.
PMID 19608588·Eur Respir J·2010
8-other
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation.
PMID 19543327·Bone Marrow Transplant·2010
8-other
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma.
PMID 19545290·Br J Haematol·2009
8-other
Impact of mass screening for gluten-sensitive enteropathy in working population.
PMID 19294762·World J Gastroenterol·2009
8-other
Fluorescence study of the dynamic interaction between E1(145-162) sequence of hepatitis GB virus C and liposomes.
PMID 19153720·Anal Bioanal Chem·2009
8-other
Behaviour of a peptide sequence from the GB virus C/hepatitis G virus E2 protein in Langmuir monolayers: its interaction with phospholipid membrane models.
PMID 19232456·Biophys Chem·2009
8-other
[Reactions to infliximab infusions in dermatologic patients: consensus statement and treatment protocol. Working Group of the Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología ].
PMID 19445874·Actas Dermosifiliogr·2009
6-review
Adjustments of water use efficiency by stomatal regulation during drought and recovery in the drought-adapted Vitis hybrid Richter-110 (V. berlandieri x V. rupestris).
PMID 18507813·Physiol Plant·2008
8-other
Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma.
PMID 18783399·Br J Haematol·2008
3-trial
Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma.
PMID 18474873·J Clin Oncol·2008
3-trial
Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIP.
PMID 18209050·J Immunol·2008
8-other
Preanalytical quality control program - an overview of results (2001-2005 summary).
PMID 18601609·Clin Chem Lab Med·2008
8-other
Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
PMID 18582203·Clin Infect Dis·2008
3-trial
HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma.
PMID 18503584·Br J Haematol·2008
8-other
Diagnostic value of duodenal antitissue transglutaminase antibodies in gluten-sensitive enteropathy.
PMID 18284655·Aliment Pharmacol Ther·2008
8-other
A monolayer study on interactions of docetaxel with model lipid membranes.
PMID 18844394·J Phys Chem B·2008
8-other
Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone.
PMID 18426893·Antimicrob Agents Chemother·2008
2-rct
Enhanced copper release from pipes by alternating stagnation and flow events.
PMID 18044522·Environ Sci Technol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12902 USF MAGNOLIA DR, CSB 7TH FLOOR ROOM: 7162
TAMPA, FL 33612 - Phone
- (813) 745-7208
Quick Facts
- NPI
- 1184656746
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile